This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury

August 1st, 2014

Acrolein, a highly reactive unsaturated aldehyde, has been shown to play a major role in the secondary injury by contributing significantly to both motor and sensory deficits.

Prof. Riyi Shi, who comes from University of Purdue in USA will highlight the recent developments in the understanding of the mechanisms of acrolein in motor and sensory dysfunction in animal models of spinal cord injury, and will also discuss the therapeutic benefits of using acrolein scavengers to attenuate acrolein-mediated neuronal damage following spinal cord injury.

The relevant study has been published in Neural Regeneration Research (Vol. 9, No. 7, 2014).

More information:
Park J, Muratori B, Shi RY. Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury. Neural Regen Res.

Provided by Neural Regeneration Research

Citation: Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury (2014, August 1) retrieved 24 April 2024 from https://sciencex.com/wire-news/168340156/acrolein-as-a-novel-therapeutic-target-for-motor-and-sensory-def.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.